LifeMD is a high-growth leading provider of direct-to-patient virtual primary care. LifeMD offers patient centric end-to-end solutions including telemedicine, laboratory and pharmacy services and specialized treatment across more than 200 conditions with a core focus on primary care. Leveraging a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group and a US-based patient care center, LifeMD is elevating healthcare by increasing access to quality affordable care. Given its comprehensive platform, the company has been able to differentiate itself from its competitors and has provided over 755,000 patient consultations to date. LifeMD also operates a non-core segment, WorkSimpli, a leading global provider of workplace and document services solutions for HR and PDF files. For more information, please visit http://www.LifeMD.com .
Quote | Conversion Labs (OTCMKTS:CVLBD)
Last: | $5.65 |
---|---|
Change Percent: | 0.36% |
Open: | $5.85 |
Close: | $5.65 |
High: | $5.85 |
Low: | $5.45 |
Volume: | 55,081 |
Last Trade Date Time: | 11/10/2020 04:55:03 pm |
News | Conversion Labs (OTCMKTS:CVLBD)
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received approval to uplist to the Nasdaq Capital Market ® . The company’s common stock will commence trading on the exchange ...
NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, reported results for the third quarter and first nine months ended September 30, 2020. All quarterly and first nine-month comp...
Message Board Posts | Conversion Labs (OTCMKTS:CVLBD)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received approval to uplist to the Nasdaq Capital Market ® . The company’s common stock will commence trading on the exchange ...
NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, reported results for the third quarter and first nine months ended September 30, 2020. All quarterly and first nine-month comp...
NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has appointed Roberto Simon to its board of directors and as the chair of its audit committee. Following his appointment, the board...